down arrow

Prothena Corp. Plc

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IE00B91XRN20
USD
11.16
0.81 (7.83%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Krystal Biotech, Inc.
Blueprint Medicines Corp.
Axsome Therapeutics, Inc.
Arrowhead Pharmaceuticals, Inc.
Intellia Therapeutics, Inc.
CRISPR Therapeutics AG
BridgeBio Pharma, Inc.
Prothena Corp. Plc
ImmunoGen, Inc.
Denali Therapeutics, Inc.
Mirati Therapeutics, Inc.
Why is Prothena Corp. Plc ?
1
Poor Management Efficiency with a low ROE of 3.07%
  • The company has been able to generate a Return on Equity (avg) of 3.07% signifying low profitability per unit of shareholders funds
2
Negative results in Jun 25
  • NET SALES(HY) At USD 7.25 MM has Grown at -94.51%
  • PRE-TAX PROFIT(Q) At USD -48.36 MM has Fallen at -66.94%
  • OPERATING CASH FLOW(Y) Lowest at USD -194.65 MM
3
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -30.37%, its profits have risen by 36%
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -30.37% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Prothena Corp. Plc for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Prothena Corp. Plc
-19.01%
-0.67
74.71%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
60.17%
EBIT Growth (5y)
-190.24%
EBIT to Interest (avg)
-111.73
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.95
Sales to Capital Employed (avg)
0.20
Tax Ratio
4.83%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
3.07%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.67
EV to EBIT
0.90
EV to EBITDA
0.92
EV to Capital Employed
-5.55
EV to Sales
-0.90
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-25.19%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-30What is not working for the Company
NET SALES(HY)

At USD 7.25 MM has Grown at -94.51%

PRE-TAX PROFIT(Q)

At USD -48.36 MM has Fallen at -66.94%

OPERATING CASH FLOW(Y)

Lowest at USD -194.65 MM

ROCE(HY)

Lowest at -66.85%

RAW MATERIAL COST(Y)

Grown by 19.63% (YoY

DEBTORS TURNOVER RATIO(HY)

Lowest at 0 times

NET PROFIT(Q)

Lowest at USD -93.16 MM

EPS(Q)

Lowest at USD -2.34

Here's what is not working for Prothena Corp. Plc
Net Sales
At USD 7.25 MM has Grown at -94.51%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (USD MM)

Pre-Tax Profit
At USD -48.36 MM has Fallen at -66.94%
over average net sales of the previous four periods of USD -28.97 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -93.16 MM has Fallen at -237.94%
over average net sales of the previous four periods of USD -27.57 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Cash Flow
Lowest at USD -194.65 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Net Profit
Lowest at USD -93.16 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)

EPS
Lowest at USD -2.34
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Debtors Turnover Ratio
Lowest at 0 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost
Grown by 19.63% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."